Language English Publication history 1981–present | Edited by Gio B. Gori | |
Abbreviated title (ISO 4) Regul. Toxicol. Pharmacol. Discipline Toxicology and Pharmacology Publisher Elsevier on behalf of the International Society of Toxicology & Pharmacology | ||
Regulatory Toxicology and Pharmacology is a monthly peer-reviewed scientific journal which covers legal aspects of toxicological and pharmacological regulations. It is published by Elsevier on behalf of the International Society of Regulatory Toxicology & Pharmacology. The current editor-in-chief is Gio Batta Gori. The journal is financed in part by the tobacco, pharmaceutical, and chemical industries.
In 2002, a group of 45 academics wrote a letter accusing the journal of a concealed pro-industry bias, saying that it "reads like an industry trade publication, but it's masked as a peer-reviewed journal" and that it lacked any "credible peer-review process". The scientists criticized the journal for failing to disclose conflicts of interest on the part of article authors and editors, citing a case in which Gori was paid $30,000 by the Tobacco Institute to publish an article in the journal dismissing the health risks of secondhand smoke.
The journal has been accused of being "broker of junk science" by the Center for Public Integrity.
Abstracting and indexing
The journal is abstracted and indexed in EMBASE, EMBiology, and Scopus.
According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.031, ranking it 56th out of 87 journals in the category "Toxicology" and 146th out of 254 journals in the category "Pharmacology & Pharmacy".